首页 | 本学科首页   官方微博 | 高级检索  
     


A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia
Authors:Elias Jabbour MD  Farhad Ravandi MD  Xuelin Huang PhD  Lianchun Xiao BS  Guillermo Garcia‐Manero MD  William Plunkett PhD  Varsha Gandhi PhD  Koji Sasaki MD  Naveen Pemmaraju MD  Naval G. Daver MD  Gautam Borthakur MD  Nitin Jain MD  Marina Konopleva MD  PhD  Zeev Estrov MD  Tapan M. Kadia MD  William G. Wierda MD  PhD  Courtney D. DiNardo MD  Mark Brandt BS  Susan M. O'Brien MD  Jorge E. Cortes MD  Hagop Kantarjian MD
Affiliation:1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TexasThe first 2 authors contributed equally to this article.;2. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas;3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas;4. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas;5. Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas;6. Chao Family Comprehensive Cancer Center, University of California at Irvine, Orange, California
Abstract:
Keywords:acute myeloid leukemia  clofarabine  fludarabine  induction  nucleoside analog
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号